低甘油-葡萄糖指数与急性失偿心力衰竭患者的死亡率之间的关联 没有糖尿病的患者
Qingqing Zhang1,2, Yanling Xu3, Si Sun1
1Department of Pan-Vascular Management Center, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, People's Republic of China.
Journal of multidisciplinary healthcare
|March 26, 2025
概括
较低的甘油三糖指数 (TyG) 与没有糖尿病的急性不补偿性心力衰竭 (ADHF) 患者的1年死亡率增加有关. 监测低TyG指数水平对于更好的患者结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 代谢综合征是代谢综合征的一种.
- 心脏衰竭研究研究
背景情况:
- 在没有糖尿病的急性不补偿性心力衰竭 (ADHF) 患者中,低甘油三糖指数 (TyG) 的预后值在很大程度上仍未被描述.
- 了解这种关系对于识别高风险个体至关重要.
研究的目的:
- 在没有糖尿病诊断的住院ADHF患者中,研究低TyG指数和1年死亡率之间的关联.
- 确定TyG指数是否可以作为这种特定患者队列中死亡率的预测标记.
主要方法:
- 一项回顾性研究包括652名没有糖尿病的住院ADHF患者.
- 主要结局是1年内全因和心血管死亡率.
- 限制立方线和多变量考克斯比例危险模型被用来分析TyG指数和死亡率之间的关联.
主要成果:
- 在一年内,TyG指数与所有原因 (HR=0.371) 和心血管死亡率 (HR=0.336) 之间发现了显著的反向关系.
- 增加的TyG指数与降低的死亡风险相关,如受限立方线分析所示.
- 观察到TyG指数和诸如高血压,BMI,年龄和心房等因素之间的相互作用是所有原因的死亡率.
结论:
- 较低的TyG指数是没有糖尿病的ADHF患者1年全因和心血管死亡率增加的重要预测指标.
- 对低TyG指数水平的临床关注是有必要的,以便在这个人群中进行风险分层和风险管理.
相关概念视频
Hypoglycemia and Glucagon
143
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
143
Diabetes: Symptoms, Diagnosis, and Complications
494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Acute Pancreatitis II: Clinical Manifestations and Management
76
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
76
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Overview of Carbohydrate Metabolism
619
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
619


